RNA-Targeting CRISPR-Cas systems and their applications
Open accessThe DOI matches its Crossref record; 80 of the 81 references it cites were found in a registry or an index.
Abstract
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)–CRISPR-associated (Cas) systems have revolutionized modern molecular biology. Numerous types of these systems have been discovered to date. Many CRISPR–Cas systems have been used as a backbone for the development of potent research tools, with Cas9 being the most widespread. While most of the utilized systems are DNA-targeting, recently more and more attention is being gained by those that target RNA. Their ability to specifically recognize a given RNA sequence in an easily programmable way makes them ideal candidates for developing new research tools. In this review we summarize current knowledge on CRISPR–Cas systems which have been shown to target RNA molecules, that is type III (Csm/Cmr), type VI (Cas13), and type II (Cas9). We also present a list of available technologies based on these systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The cas clusters described in PCC 9108 mainly belong to type III CRISPR -Cas systems, the most diverse and complex CRISPR, able to cleave RNA and DNA, and the only known that use three nuclease ac tivities (Burmistrz et al., 2020; Molina et al., 2020) (Table 1).”
From Characterization of Limnospira platensis PCC 9108 R-M and CRISPR-Cas systems (2024) · cites this paper as Burmistrz et al., 2020
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116 · cited 3×
“The strand containing complementary to crRNA and the displaced strand are cleaved by HNH and RuvC domains, respectively [9,56].”
BackgroundMethodCRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947 · cited 1×
“During the adaptation phase, new spacers are incorporated into the CRISPR array into its leader end [6].”
BackgroundNucleic acid detection with CRISPR-Cas13a/C2c2
Gootenberg, J. S., Abudayyeh, O. O., Lee, J. W., Essletzbichler, P., Dy, A. J., Joung, J., Verdine, V., Donghia, N., Daringer, N. M., Freije, C. A., et al. (2017) · Science · doi:10.1126/science.aam9321 · Cited by 3,844 · cited 9×
“An example for that is its utilization as a backbone for in vitro detection method of DNA and RNA named Specific High-Sensitivity Enzymatic Reporter unLOCKing (SHERLOCK) [67].”
BackgroundMethodInfluentialMultiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6
Gootenberg, J. S., Abudayyeh, O. O., Kellner, M. J., Joung, J., Collins, J. J., & Zhang, F. (2018) · Science · doi:10.1126/science.aaq0179 · Cited by 2,638 · cited 5×
“The potential clinical applications of RNA-targeting CRISPR–Cas systems include but are not limited to: rapid detection of various nucleic acids [67,68], treatment of diseases related to G to A mutations using RNA editing [66], treatment of genetic diseases using RNA knockdown, treatment of diseases related to incorre…”
BackgroundMethodInfluentialCRISPR RNA Maturation by Trans-Encoded Small RNA and Host Factor RNase III
Deltcheva, E., Chylinski, K., Sharma, C. M., Gonzales, K., Chao, Y., Pirzada, Z. A., Eckert, M. R., Vogel, J., & Charpentier, E. (2011) · Nature · doi:10.1038/nature09886 · Cited by 2,563 · cited 2×
“The 5′ fragment of tracrRNA binds to a repeat sequence, creating a duplex which is cleaved by RNase III [8].”
BackgroundC2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector
Abudayyeh, O. O., Gootenberg, J. S., Konermann, S., Joung, J., Slaymaker, I. M., Cox, D. B. T., Shmakov, S., Makarova, K. S., Semenova, E., Minakhin, L., et al. (2016) · Science · doi:10.1126/science.aaf5573 · Cited by 2,336 · cited 6×
“To date, four subtypes have been distinguished: VI-A (that uses Cas13a variant, alternatively known as C2c2), VI-B (Cas13b/C2c6), VI-C (Cas13c/C2c7), and VI-D (Cas13d) [47,48].”
BackgroundInfluentialRNA targeting with CRISPR–Cas13
Abudayyeh, O. O., Gootenberg, J. S., Essletzbichler, P., Han, S., Joung, J., Belanto, J. J., Verdine, V., Cox, D. B. T., Kellner, M. J., Regev, A., et al. (2017) · Nature · doi:10.1038/nature24049 · Cited by 2,093 · cited 6×
“To date, four subtypes have been distinguished: VI-A (that uses Cas13a variant, alternatively known as C2c2), VI-B (Cas13b/C2c6), VI-C (Cas13c/C2c7), and VI-D (Cas13d) [47,48].”
BackgroundInfluentialCRISPRFinder: a web tool to identify clustered regularly interspaced short palindromic repeats
Grissa, I., Vergnaud, G., & Pourcel, C. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm360 · Cited by 1,875 · cited 1×
“CRISPR–Cas systems are very common in the prokaryotic world, as they are detected in around half of the bacterial and archeal species known to date [17,21].”
BackgroundCox, D. B. T., Gootenberg, J. S., Abudayyeh, O. O., Franklin, B., Kellner, M. J., Joung, J., & Zhang, F. (2017) · Science · doi:10.1126/science.aaq0180 · Cited by 1,834 · cited 7×
“RNA editing Cas13b (REPAIR) dCas13b is fused to ADAR2 domain enables to convert selected adenosine to inosine small size enables delivery via AAV [66]”
BackgroundMethodInfluentialIdentification of genes that are associated with DNA repeats in prokaryotes
Jansen, R., Embden, J. D. A. V., Gaastra, W., & Schouls, L. M. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02839.x · Cited by 1,802 · cited 1×
“Together with the leader sequence these spacers and repeats constitute the CRISRP array [4,5].”
Background
Cited by
Items 101–131 of 131
Nadin‐Davis, S. A., Pope, L., Devenish, J., Allain, R., & Ogunremi, D. (2022) · AIMS Microbiology · doi:10.3934/microbiol.2022022 · Cited by 1
Tapiero, D. Y. M., Rentería, M. A. M., & Kurmen, J. E. C. (2024) · Revista Mutis · doi:10.21789/22561498.2044 · Cited by 1
Employment of RNA Interference and CRISPR/Cas Machinery for Disease Resistance in Crops
Imran, I., Awan, M. J. A., Akhtar, M., Sajjad, M. W., Buzdar, M. I., Zahid, R., Khan, J., Amin, I. U., & Naqvi, R. Z. (2025) · Wiley eBooks · doi:10.1002/9781394280049.ch16 · Cited by 1
CRISPR-Cas13 and its Applications in Human Therapeutics
Rao, K. (2021) · Journal of High School Science · doi:10.64336/001c.30072 · Cited by 1
COVID-19: CRISPR/Cas-like System of nsp3 Promotes the Mutant Recombination and Drug ResistancePreprint
wenzhong, L., & hualan, L. (2021) · ChemRxiv · doi:10.26434/chemrxiv.14394284
Molecular mechanisms underlying cortical (mal)formation: case studies of ESCO2 and EXOSC10
Ulmke, P. A. (2021) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8819
Application of CRISPR Cas systems in DNA recorders and writers
Sen, D., & Mukhopadhyay, P. (2023) · Biosystems · doi:10.1016/j.biosystems.2023.104870
Template-based genome editing directed by the SviCas3Preprint
Tong, W., Yu, Z.-F., Li, Y., Ye, S., Yong, D.-X., Wang, A.-J., Tang, Y., Xu, X., Qiu, C.-H., Yang, X., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2518711/v1
Template-based eukaryotic genome editing directed by SviCas3Preprint
Tong, W., Li, Y., Ye, S., Wang, A.-J., Tang, Y., Li, M., Yu, Z.-F., Xia, T., Liu, Q.-Y., & Zhu, S. (2023) · arXiv (Cornell University) · doi:10.48550/arxiv.2305.05861
Leclerc, D. (2023) · theses.fr (ABES) · doi:10.70675/265eb7f7zf02bz4293z9d8dz266599d45d4a
Antiabiotic Stress Capacities of Crops Gained by CRISPR/Cas‐Edited Small RNAs
Saifullah, A., Azeem, A., Mustafa, G., Khan, M. S., Shehzadi, S., Parvaiz, A., Rehman, M., & Joyia, F. A. (2025) · Wiley eBooks · doi:10.1002/9781394280049.ch17
Targeted Protein Modification with an Antibody-Based System
Rimon, O., Konč, J., Černauskienė, I., Ali, M., Chowdhury, V. R., Sormanni, P., Bernardes, G. J. L., & Vendruscolo, M. (2025) · ACS Central Science · doi:10.1021/acscentsci.5c00651
Cryo-EM structure of the RfxCas13d-crRNA-off-target-RNA complex
Yang, Q., Sun, Y., Sun, L., Chi, T., & Chen, Z. (2025) · Structure · doi:10.1016/j.str.2025.09.010
Yheskel, M., Sidoli, S., & Secombe, J. (2024) · Figshare · doi:10.6084/m9.figshare.26569606
Yheskel, M., Sidoli, S., & Secombe, J. (2024) · Figshare · doi:10.6084/m9.figshare.26569609
Yheskel, M., Sidoli, S., & Secombe, J. (2024) · Figshare · doi:10.6084/m9.figshare.26569621
Yheskel, M., Sidoli, S., & Secombe, J. (2024) · Figshare · doi:10.6084/m9.figshare.26569618
Yheskel, M., Sidoli, S., & Secombe, J. (2024) · Figshare · doi:10.6084/m9.figshare.26569603
Yheskel, M., Sidoli, S., & Secombe, J. (2024) · Figshare · doi:10.6084/m9.figshare.26569624
Yheskel, M., Sidoli, S., & Secombe, J. (2024) · Figshare · doi:10.6084/m9.figshare.26569615
Research progress of Class 2 CRISPR-Cas system in nucleic acid detection of animal pathogens
ZHANG, S., Xi, S. H. E. N., Zhongzhi, L. I. U., Debao, H. U., Xin, L. I., Yiwen, G. U. O., Xiangbin, D. I. N. G., & ZHANG, L. (2025) · Frontiers of Agricultural Science and Engineering · doi:10.15302/j-fase-2025659
MICROBIAL INNOVATION AND RESISTANCE MANAGEMENT THROUGH CRISPR-CAS TECHNOLOGY
(2025) · Journal of Bio Innovation · doi:10.46344/jbino.2025.v14i05.18
CRISPR/Cas12a-Based Biosensors and Applications in Cereal Safety
Baştürk, F. N., Kırkıncı, S., Yıldırım, N., Unlu, Y. S., Morgil, H., Çağla, E., Çevik, B., Boztaş, K., Öz, G., & Gerçek, Y. C. (2026) · Sustainability Sciences in Asia and Africa · doi:10.1007/978-981-95-6722-5_4
Li, L., & Ding, G. (2026) · Industrial Crops and Products · doi:10.1016/j.indcrop.2026.123044
CRISPR-Cas Systems: Mechanisms, Variants, and Biomedical Applications: A Comprehensive Review
Ihim, A. C., Obi, K. C., Obi, P. C., Edeh, I., Ozuruoke, D. F. N., & Ikwelle, T. A. (2026) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v16i4.7692
Quaye, J. K. (2026) · Institutional Repository of Leibniz Universität Hannover (Leibniz Universität Hannover) · doi:10.15488/21213
Rasool, H. M. H., Chen, Q., Gao, W., Ahmed, I., Peng, C., Che, L., Li, Z., Gong, X., & Zhou, J. (2026) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2026.118985
Gene Editing for Abiotic Stress Tolerance
Qadri, T. A., Waseem, M., Basharat, S., Liu, P., Khan, A., & Imtiaz, M. (2026) · IGI Global eBooks · doi:10.4018/979-8-3373-9534-0.ch006
Barış, B. (2025) · Yildiz Technical University - AVESIS
Metadata
- Authors
- Burmistrz, M., Krakowski, K., & Krawczyk-Balska, A.
- Affiliations
- Department of Molecular Microbiology, Biological and Chemical Research Centre, Faculty of Biology, University of Warsaw, 02-089 Warsaw, Poland
- University of Warsaw (PL)
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-02-07
- Volume
- 21
- Issue
- 3
- Pages
- 1122
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7036953
- OpenAlex
- W3004935084
- Cited by
- 125
- References
- 81
- Citations by year
- 2026: 11 · 2025: 13 · 2024: 18 · 2023: 21 · 2022: 30 · 2021: 24 · 2020: 8
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Center of Science, Poland (2016/21/B/NZ6/00963)
- Ministry of Science and Higher Education through the Faculty of Biology, University of Warsaw (intramural grant DSM no. 501-D114-01-1140400)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- CRISPR/Cas9, Cas13, type III CRISPR-Cas, RNA interference, RNA cleavage, genome editing tools
- MeSH terms
- Gene Editing, Animals, Humans, CRISPR-Cas Systems, CRISPR-Associated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.